🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to show that subcutaneous (SC) administration ...
Status
Completed
Location
Dana Farber Cancer Institute
Start Date
2017-10-27
Trial ID
NCT03277105
The purpose of this study is to evaluate the tolerability and safety of sub...
Status
Completed
Location
National Hospital Organization Shibukawa Medical Center
Start Date
2017-08-10
Trial ID
NCT03242889
Treatments Being Tested
This phase I trial studies the possible benefits and side effects of adding...
Status
Terminated
Location
Ohio State University Comprehensive Cancer Center
Start Date
2021-09-27
Trial ID
NCT04956302
Treatments Being Tested
The primary objective of this study is to determine whether treatment with ...
Status
Completed
Location
Arizona Oncology Associates, PC - HAL
Start Date
2017-11-07
Trial ID
NCT03301220
Treatments Being Tested
This is an open-label, multicenter, Phase 2 study in subjects with newly di...
Status
Completed
Location
Hopitaux Universitaires Henri-Mondor
Start Date
2019-09-23
Trial ID
NCT04131309
Treatments Being Tested
This phase III trial compares the combination of four drugs (daratumumab, b...
Status
Recruiting
Location
Anchorage Associates in Radiation Medicine
Start Date
2021-02-24
Trial ID
NCT04566328
This phase I trial studies the side effects and best dose of selvigaltin wh...
Status
Withdrawn
Location
Roswell Park Cancer Institute
Start Date
2026-04-01
Trial ID
NCT07082270
Treatments Being Tested
The purpose of this study is to evaluate the safety and pharmacokinetic of ...
Status
Completed
Location
Peking University Third Hospital
Start Date
2019-12-25
Trial ID
NCT04121260
Treatments Being Tested
This phase II trial compares the combination of selinexor, daratumumab and ...
Status
Active Not Recruiting
Location
UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care
Start Date
2024-07-23
Trial ID
NCT06169215
This clinical trial tests the treatment effect of home based daratumumab ad...
Status
Completed
Location
Sidney Kimmel Cancer Center at Thomas Jefferson University
Start Date
2022-11-08
Trial ID
NCT05511428